MYDRIAFAIR Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Mydriafair, and when can generic versions of Mydriafair launch?
Mydriafair is a drug marketed by Pharmafair and is included in two NDAs.
The generic ingredient in MYDRIAFAIR is tropicamide. There are seven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the tropicamide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Mydriafair
A generic version of MYDRIAFAIR was approved as tropicamide by BAUSCH AND LOMB on July 27th, 1994.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MYDRIAFAIR?
- What are the global sales for MYDRIAFAIR?
- What is Average Wholesale Price for MYDRIAFAIR?
Summary for MYDRIAFAIR
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 110 |
| Patent Applications: | 4,067 |
| DailyMed Link: | MYDRIAFAIR at DailyMed |
US Patents and Regulatory Information for MYDRIAFAIR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pharmafair | MYDRIAFAIR | tropicamide | SOLUTION/DROPS;OPHTHALMIC | 088274-001 | Sep 16, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Pharmafair | MYDRIAFAIR | tropicamide | SOLUTION/DROPS;OPHTHALMIC | 088230-001 | Sep 16, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
